We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AYV:EURONEXT PARISAyvens Analysis

Data as of 2026-03-12 - not real-time

SGD 0.19

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The 20‑day SMA (≈0.21) sits comfortably above the 50‑day (≈0.19) and 200‑day (≈0.07) averages, signaling a bullish trend despite the current price of 0.185 SGD hovering just above the identified support of 0.173 SGD. RSI is near 45, indicating neutral momentum, while the MACD line trails its signal, producing a bearish histogram. Trading volume has slipped to 6,000 shares, far below the 10‑day average of ~58,000, pointing to waning liquidity. Volatility is extreme, with a 30‑day swing of over 110 %, and the market sentiment index reads “Extreme Greed” at 78.16. The stock’s beta is unusually negative (‑5.6), suggesting atypical price behavior relative to the market. Together, these metrics paint a picture of a technically bullish but fragile price action.
Fundamentally, revenue has contracted by 20 % year‑over‑year and margins are deep in the red, with operating and profit margins of –14.5 % and –17 % respectively, and a trailing EPS of –0.02 SGD. The balance sheet shows a modest cash cushion of 1.6 M SGD against 0.68 M SGD of debt, yet the price‑to‑book ratio of 14.2× far exceeds the book value per share of 0.013 SGD, indicating a premium valuation on equity. A discounted cash‑flow model estimates a fair value of 0.217 SGD, implying upside from the current 0.185 SGD price. However, negative ROE (‑83 %) and ROA (‑11 %) underscore operational weakness, and the company pays no dividend. The combination of a potential valuation gap and a distressed earnings profile creates a mixed outlook that leans toward value‑oriented caution.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price is barely above the identified support level, limiting upside potential
  • Bearish MACD histogram indicates short‑term momentum weakness
  • Trading volume has declined sharply, raising liquidity concerns

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Bullish SMA hierarchy clashes with bearish MACD, creating mixed technical signals
  • Extreme 30‑day volatility and a highly negative beta amplify price swings
  • Continued negative earnings and margins constrain near‑term profitability

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF fair‑value estimate of ~0.217 SGD suggests upside from current pricing
  • Cash reserves exceed debt, providing a cushion for a potential turnaround
  • A recovery in the consumer‑cyclical auto‑parts sector could revive revenue growth

Key Metrics & Analysis

Financial Health

Revenue Growth-20.20%
Profit Margin-17.27%
ROE-82.96%
ROA-11.09%
Debt/Equity62.00
P/B Ratio14.2
Op. Cash FlowSGD371.0K
Free Cash FlowSGD729.8K

Technical Analysis

TrendBullish
RSI44.8
SupportSGD 0.17
ResistanceSGD 0.33
MA 20SGD 0.21
MA 50SGD 0.19
MA 200SGD 0.07
MACDBearish
VolumeDecreasing
Fear & Greed Index78.16

Valuation

Fair ValueSGD 0.22
GradeUndervalued
TypeValue

Risk Assessment

Beta-5.62
Volatility110.30%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskHigh
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.